Generic Oncology Drugs Market to Display Growth at a CAGR of 6.2% in 2028

1. Generic Oncology Drugs Market to Display Growth at a CAGR of 6.2% in 2028 Healthcare, Pharmaceuticals & Medical Devices February 2019 Report Id : REP-GB-8961 Status : Publish Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved

2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitiveframework,and future markettrends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing– the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research ©2015 Future Market Insights, All Rights Reserved 2

3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 FMI formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B 4 FMI conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Data collection      Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Company Analysis Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data 5 Data validation 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 FMI delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3

4. Generic Oncology Drugs Market Analysis Increasing incidences of cancer have been detected, ascending from the proclivity for cigarettes and tobacco among individuals. The number of cancer-infected patients is stimulated by viral infections, carcinogens, lack of physical activities, genetic causes, age, and unhealthy eating habits. Recent developments in the healthcare sector have broadened the scope of therapies for the treatment of cancer by leveraging oncology. Demand for generic oncology drugs has witnessed sheer increase, by dint of its property to treat numerous types of cancer such as colorectal, lung, prostate, and multiple myeloma. With the ubiquity of cancer, several health organizations across the world are hard pressed to develop a potent cure for the treatment of cancer. In addition to this, a high number of deaths occurring on account of cancer has amplified the research and development endeavors of medical organizations to prevent cancer altogether. Government initiatives to enhance the medical conditions by encouraging the development of novel drugs has been a crucial factor for the rapid expansion of the generic oncology drugs market. Furthermore, the reimbursement policies of government have equipped the manufacturers of the industry with an attractive opportunity to boost the production of generic oncology drugs, which has been a vital factor for the sustainable growth of the generic oncology drugs market. Analyzing a cohort of these factors, the global generic oncology drugs market is poised to surpass a stunning CAGR of 6.2% through 2028. ©2015 Future Market Insights, All Rights Reserved 4

5. Generic Oncology Drugs Market Analysis North America Enjoys a Dominant Share in the Global Generic Oncology Drugs Market; Europe and Asia-Pacific Next in Rank Extensive analysis carried out on the generic oncology drugs market has presented region-wise insights on the demand drivers, restraints, and opportunities that influence the growth of the market. Regions analyzed in this report includes North America, Europe Asia-Pacific, and Rest of the World. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8961 Rising awareness of novel innovations and therapies for the treatment of cancer are projected to offer lucrative growth opportunities to the generic oncology drugs market. Increase in the demand for generic oncology drugs is further intensified in North America, on account of personalized medicines, novel generic oncology drugs launches and a rising rate of strategic partnerships and collaborations in this region. Following the footsteps of North America, Europe has witnessed affluent growth in the generic oncology drugs market with the increasing consciousness of the generic oncology drugs for cancer therapies. Emerging economies of Asia-Pacific like India and China are expected to contribute to the growth of the generic oncology drugs market, owing to the increasing cognizance of the disease and advancements in the development of the generic oncology drugs. ©2015 Future Market Insights, All Rights Reserved 5

6. Generic Oncology Drugs Market Analysis A Look at the Competitive Matrix for the Generic Oncology Drugs Market The report opines that the burgeoning trend of mergers and acquisitions has been witnessed in the generic oncology drugs market, which is expected to influence the growth of the global generic oncology drugs market. Key players transforming the scenario of the generic oncology drugs market are Bayer Healthcare AG, Amgen, Teva Pharmaceutical Industries, Pfizer, Boehringer Ingelheim GmbH, AstraZeneca, Hoffmann-La Roche Ltd., Eli Lily and Company, ARIAD Pharmaceuticals, Inc., GlaxoSmithKline, CELGENE Corporation, Novartis AG, Johnson and Johnson, AbbVie Inc., Merck & Co., and Sanofi, among others. The business strategies and recent developments adopted by these players have been incorporated in the report, which will help the stakeholders of this market gain valuable insights into the competitive matrix of the global generic oncology drugs market. Recent Developments in the Global Generic Oncology Drugs Market CELGENE, Novartis, and Roche have been significant players in the generic oncology drugs market with their far-reaching product portfolio and pipeline products and they procure a considerable market share. Therapies and generic oncology drugs developed by Roche such as Avastin, Herceptin, and Rituxan witnessed a rapid adoption. ©2015 Future Market Insights, All Rights Reserved 6

7. Generic Oncology Drugs Market Analysis Strategic alliances formed by the companies of the generic oncology drugs market have aided them in intensifying their endeavors towards developing generic oncology drugs with high efficacy. These thoughtful strategies have proved lucrative for these players and helped them retain their supreme position in the generic oncology drugs market. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-8961 Click here to Order a free sample ©2015 Future Market Insights, All Rights Reserved 7

8. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You ©2015 Future Market Insights, All Rights Reserved 8